EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Feasibility and preliminary clinical outcomes of medical thoracoscopic bulla volume reduction for giant emphysematous bulla

Rui Xu iD, Xinmiao Du, Ling Zuo, Jingyu Shi, Yongxiao Luo, Tao Zhang, Dan Liu, Kaige Wang iD

Therapeutic Advances in Respiratory Disease · 2026-07 · 20

DOI: 10.1177/17534666261465491 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 13.07.2026. Verfasst von Rui Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan Unive…. Hauptthemen laut MEDLINE: Pulmonary Emphysema, Blister, Pneumonectomy, Thoracoscopy. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Noncommunicable Chronic DiseasesNational Science and Technology Major Project, National Natural Science Foundation of China, 1·3·5Project of State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Giant emphysematous bulla (GEB) is a form of emphysematous lung destruction and patients experience progressive dyspnea and decline in quality of life. Conventional surgical reduction is not available for all patients, especially those in poor condition, and a less invasive approach is needed.

Objectives

This study aimed to evaluate the feasibility and preliminary clinical outcomes of medical thoracoscopic bulla volume reduction for GEB.

Design

Single-center retrospective observational study.

Methods

A total of 35 GEB patients who underwent medical thoracoscopic bulla volume reduction were retrospectively analyzed. Preoperative and postoperative clinical data and chest computed tomography were collected. The feasibility of the technique was evaluated by radiological changes (bullae volume and diameter) and postoperative complications. Improvement in dyspnea was assessed using the modified Medical Research Council (mMRC) dyspnea scale. Accessible six-minute walk distance (6MWD) and spirometry test follow-up data were analyzed to assess preliminary clinical functional improvement.

Results

The targeted bulla volume was 1183.8 ± 636.7 mL preoperatively and decreased to 169.2 ± 237.2 mL postoperatively, representing an 87.7 ± 17.1% decrease compared to the baseline. A total of 91.4% (32/35) of the patients achieved more than 50% volume reduction relative to baseline, and the diameter of the targeted bulla also showed a significant decrease ( p < 0.0001). Nine subcutaneous emphysema cases and one thoracic infection case were reported as postoperative complications. In the overall population, the mMRC score decreased by 1.2 ± 0.6 points at the 6-month follow-up. Available follow-up data on 6MWD and spirometry tests also showed improvement.

Conclusion

Medical thoracoscopic bulla volume reduction may represent a feasible and less invasive therapeutic option for patients with GEB and demonstrated preliminary clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmphysemaBlisterPneumonectomyThoracoscopyLungHumansFeasibility StudiesFemaleMaleRetrospective StudiesTreatment OutcomeMiddle AgedAgedDyspneaTomography, X-Ray ComputedWalk TestSpirometryTime FactorsQuality of LifePostoperative ComplicationsRecovery of Function

Stichwörter der Autor:innen

giant emphysematous bullamedical thoracoscopytreatment

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
  • Hangzhou Broncus Medical Co., Ltd., Hangzhou, Zhejiang Province, China.
  • Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan Province 61004…

ORCID-Profile: Rui Xu, Kaige Wang

Förderung

  • Noncommunicable Chronic DiseasesNational Science and Technology Major Project
  • National Natural Science Foundation of China
  • 1·3·5Project of State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University

Zitieren

APA

Xu, R., Du, X., Zuo, L., Shi, J., Luo, Y., Zhang, T., Liu, D., & Wang, K. (2026). Feasibility and preliminary clinical outcomes of medical thoracoscopic bulla volume reduction for giant emphysematous bulla. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261465491

Vancouver

Xu R, Du X, Zuo L, Shi J, Luo Y, Zhang T, et al. Feasibility and preliminary clinical outcomes of medical thoracoscopic bulla volume reduction for giant emphysematous bulla. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261465491

BibTeX
@article{Xu2026,
  author = {Xu, Rui and Du, Xinmiao and Zuo, Ling and Shi, Jingyu and Luo, Yongxiao and Zhang, Tao and Liu, Dan and Wang, Kaige},
  title = {Feasibility and preliminary clinical outcomes of medical thoracoscopic bulla volume reduction for giant emphysematous bulla},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2026},
  volume = {20},
  doi = {10.1177/17534666261465491}
}
Kostenlos starten →